down arrow

Bal Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE083D01012
  • NSEID: BALPHARMA
  • BSEID: 524824
INR
105.70
2.83 (2.75%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 30.6 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

103.40108.25

52 Week

76.30157.90
Valuation
Technical
Day's Volume

CASH

30.6 k (-92.57%) Volume

Shareholding (Mar 2025)

FII

0.14%

Held by 3 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

50.86%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.12 times

  • Poor long term growth as Net Sales has grown by an annual rate of 10.42% over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.12 times
  • The company has been able to generate a Return on Equity (avg) of 6.77% signifying low profitability per unit of shareholders funds
2

Negative results in Dec 24

3

Stock is technically in a Mildly Bearish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 168 Cr (Micro Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

1.17%

stock-summary
Debt Equity

1.89

stock-summary
Return on Equity

11.14%

stock-summary
Price to Book

2.38

Revenue and Profits (1 Year):
Net Sales:
73 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.17%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-16.84%
0%
-16.84%
1 Year
2.32%
1.16%
3.48%
2 Years
44.1%
2.67%
46.77%
3 Years
-9.66%
3.24%
-6.42%
4 Years
60.88%
4.81%
65.69%
5 Years
130.53%
11.76%
142.29%

Latest dividend: 1.2 per share ex-dividend date: Sep-17-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
10.42%
EBIT Growth (5y)
41.84%
EBIT to Interest (avg)
1.17
Debt to EBITDA (avg)
7.30
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.46
Tax Ratio
11.45%
Dividend Payout Ratio
25.66%
Pledged Shares
0
Institutional Holding
0.14%
ROCE (avg)
7.49%
ROE (avg)
6.77%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
33
Price to Book Value
2.38
EV to EBIT
13.51
EV to EBITDA
9.33
EV to Capital Employed
1.48
EV to Sales
0.93
PEG Ratio
0.22
Dividend Yield
1.17%
ROCE (Latest)
10.81%
ROE (Latest)
11.14%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 3 FIIs (0.14%)

Promoter with highest holding

Shailesh Siroya (17.24%)

Highest Public shareholder

Prakash Chandra Jain (3.65%)

Individual Investors Holdings

32.49%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -10.42% vs 6.58% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -46.07% vs 56.14% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "73.15",
          "val2": "81.66",
          "chgp": "-10.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.76",
          "val2": "7.79",
          "chgp": "-0.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.01",
          "val2": "3.66",
          "chgp": "36.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.48",
          "val2": "0.89",
          "chgp": "-46.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.61%",
          "val2": "9.54%",
          "chgp": "1.07%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -9.13% vs 12.25% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 26.21% vs 157.50% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "148.05",
          "val2": "162.93",
          "chgp": "-9.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.16",
          "val2": "14.14",
          "chgp": "0.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.89",
          "val2": "7.46",
          "chgp": "5.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.30",
          "val2": "1.03",
          "chgp": "26.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.56%",
          "val2": "8.68%",
          "chgp": "0.88%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -9.56% vs 10.29% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -7.29% vs 97.94% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "221.20",
          "val2": "244.59",
          "chgp": "-9.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "21.92",
          "val2": "21.93",
          "chgp": "-0.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "12.90",
          "val2": "11.12",
          "chgp": "16.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.78",
          "val2": "1.92",
          "chgp": "-7.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.91%",
          "val2": "8.97%",
          "chgp": "0.94%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 11.50% vs 8.18% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 187.55% vs -54.19% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "339.22",
          "val2": "304.22",
          "chgp": "11.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "31.53",
          "val2": "25.40",
          "chgp": "24.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "15.26",
          "val2": "12.49",
          "chgp": "22.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.39",
          "val2": "2.57",
          "chgp": "187.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.29%",
          "val2": "8.35%",
          "chgp": "0.94%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
73.15
81.66
-10.42%
Operating Profit (PBDIT) excl Other Income
7.76
7.79
-0.39%
Interest
5.01
3.66
36.89%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.48
0.89
-46.07%
Operating Profit Margin (Excl OI)
10.61%
9.54%
1.07%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is -10.42% vs 6.58% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is -46.07% vs 56.14% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
148.05
162.93
-9.13%
Operating Profit (PBDIT) excl Other Income
14.16
14.14
0.14%
Interest
7.89
7.46
5.76%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.30
1.03
26.21%
Operating Profit Margin (Excl OI)
9.56%
8.68%
0.88%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -9.13% vs 12.25% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 26.21% vs 157.50% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
221.20
244.59
-9.56%
Operating Profit (PBDIT) excl Other Income
21.92
21.93
-0.05%
Interest
12.90
11.12
16.01%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.78
1.92
-7.29%
Operating Profit Margin (Excl OI)
9.91%
8.97%
0.94%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -9.56% vs 10.29% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -7.29% vs 97.94% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
339.22
304.22
11.50%
Operating Profit (PBDIT) excl Other Income
31.53
25.40
24.13%
Interest
15.26
12.49
22.18%
Exceptional Items
0.00
0.00
Consolidate Net Profit
7.39
2.57
187.55%
Operating Profit Margin (Excl OI)
9.29%
8.35%
0.94%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 11.50% vs 8.18% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 187.55% vs -54.19% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Bal Pharma Ltd stock-summary
stock-summary
Bal Pharma Ltd
Micro Cap
Pharmaceuticals & Drugs
Bal Pharma Ltd (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May '87. In Mar.'90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations.
Company Coordinates stock-summary
Company Details
21 & 22 Bommasandra Indl Area, Hosur Road Bangalore Karnataka : 560092
stock-summary
Tel:
stock-summary
http://www.balpharma.com
stock-summary
secretarial@balpharma.com/info@balp
Registrar Details
TSR Darashaw Ltd, 6-10 , Haji Moosa Patrawala Indl. Est , 20 Dr.E.Moses Road , Mahalaxmi , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."